Join
Live feed
·
INSIDERFilingvia Quantisnow
Collegium Pharmaceutical Inc. logo

Director Heffernan Michael Thomas was granted 4,820 shares, increasing direct ownership by 11% to 50,328 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
COLL· Collegium Pharmaceutical Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track COLL (Collegium Pharmaceutical Inc.) and more on Quantisnow.